Abstract 177: Exploratory Results From the B01-02 Trial: Administration of MultiStem® Results in Decreased Circulating CD3+ Cells and Lower Levels of Inflammatory Cytokines
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 May 2021.
All research outputs
#18,807,229
of 23,308,124 outputs
Outputs from Stroke
#10,466
of 11,737 outputs
Outputs of similar age
#290,252
of 399,732 outputs
Outputs of similar age from Stroke
#143
of 151 outputs
Altmetric has tracked 23,308,124 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,737 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.8. This one is in the 5th percentile – i.e., 5% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 399,732 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 151 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.